Raia Drogasil S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 07, 2023
Share
Raia Drogasil S.A. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was BRL 8,442.32 million compared to BRL 7,178.76 million a year ago. Net income was BRL 338.19 million compared to BRL 354.84 million a year ago. Basic earnings per share from continuing operations was BRL 0.1942 compared to BRL 0.2071 a year ago.
For the six months, sales was BRL 16,373.66 million compared to BRL 13,741.27 million a year ago. Net income was BRL 530.45 million compared to BRL 495.48 million a year ago. Basic earnings per share from continuing operations was BRL 0.3045 compared to BRL 0.2892 a year ago.
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows:
- branded pharmaceuticals (42%);
- pharmaceutical additives (25.1%) ;
- OTC products (21.3%);
- generic pharmaceutical products (11.4%).
At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.
RAIA DROGASIL S.A. 
